Audiologists in Waterbury, CT Accepting Medicare

9 Audiologists found. Showing 1 - 9

Dr. Samantha N Hauser, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 22 Tompkins St Ste 1, Waterbury, CT 06708 Phone: 702-768-7057

Ms. Lisa Marie Andrighetti, MS Audiologist Medicare: Accepting Medicare Assignments Practice Location: 60 Westwood Ave, Suite 102, Waterbury, CT 06708 Phone: 203-346-1328    Fax: 203-574-5987

Mrs. Melynda Michelle Jose, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1 Exchange Pl, 21 West Main Street, 3rd Floor, Waterbury, CT 06702 Phone: 203-574-3777

Kay Yanagisawa, M.S. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 22 Tompkins St, Easter Seals, Waterbury, CT 06708 Phone: 203-754-5141

Sharon A Bellonio, M.S. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 22 Tompkins St, Waterbury, CT 06708 Phone: 203-754-5141

Caitlin Cann, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 171 Grandview Ave, Suite 201, Waterbury, CT 06708 Phone: 203-578-4630

Natalie Silvia, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 21 W Main St Fl 3, Waterbury, CT 06702 Phone: 203-574-3777

Mrs. Ronni Ellen Mathews, M.S., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 171 Grandview Ave, Waterbury, CT 06708 Phone: 203-753-8833    Fax: 203-753-3744

Lori M Cooney, AUD., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 3600 E Main St, Waterbury, CT 06705 Phone: 203-000-0000

News Archive

Vitamin A supplements can reduce malaria cases in children by one-third, study finds

In malaria-endemic areas, vitamin A supplements - which cost about 2 U.S. cents each - can help reduce infections in children by one-third, according to a study published in the Malaria Journal, IRIN reports.

Incyte receives FDA approval for Jakafi to treat intermediate or high-risk MF

Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi (ruxolitinib) for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.

First potential biomarker identified for postural orthostatic tachycardia syndrome

New research from The University of Toledo College of Medicine and Life Sciences strongly suggests postural orthostatic tachycardia syndrome, or POTS, is an autoimmune disorder and may help pave the way for a simple blood test that could help physicians diagnose the condition.

Sequence of immunizations could be the promising route to HIV vaccine

The secret to preventing HIV infection lies within the human immune system, but the more-than-25-year search has so far failed to yield a vaccine capable of training the body to neutralize the ever-changing virus. New research from The Rockefeller University, and collaborating institutions, suggests no single shot will ever do the trick. Instead, the scientists find, a sequence of immunizations might be the most promising route to an HIV vaccine.

Read more Medical News

› Verified 1 days ago